333

CJ BIOSCIENCE

No trades
See on Supercharts
Market capitalization
‪130.86 B‬KRW
−3370KRW
‪−22.91 B‬KRW
‪5.58 B‬KRW
‪4.51 M‬
Beta (1Y)
0.80

About CJ BIOSCIENCE

CEO
Jong-Sik Chun
Headquarters
Jung-gu
Employees (FY)
137
Founded
2009
ISIN
KR7311690002
FIGI
BBG00QXV4WF6
CJ Bioscience, Inc. engages in the research and development of biotechnology and in the provision of solutions for microbiological researches including biomedicine, institutional research and development and genetic sequencing. The company was founded by Jong Sik Chun on November 18, 2009 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 311690 is 13630 KRW — it has decreased by 5.08% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CJ BIOSCIENCE stocks are traded under the ticker 311690.
311690 stock is 8.13% volatile and has beta coefficient of 0.80. Check out the list of the most volatile stocks — is CJ BIOSCIENCE there?
Yes, you can track CJ BIOSCIENCE financials in yearly and quarterly reports right on TradingView.
311690 stock has fallen by 9.13% compared to the previous week, the month change is a 7.09% fall, over the last year CJ BIOSCIENCE has showed a 60.93% decrease.
311690 net income for the last quarter is ‪1.75 B‬ KRW, while the quarter before that showed ‪−7.81 B‬ KRW of net income which accounts for 122.40% change. Track more CJ BIOSCIENCE financial stats to get the full picture.
Today CJ BIOSCIENCE has the market capitalization of ‪130.86 B‬, it has decreased by 1.91% over the last week.
No, 311690 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 311690 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CJ BIOSCIENCE stock right from TradingView charts — choose your broker and connect to your account.
311690 reached its all-time high on Jul 23, 2021 with the price of 62650 KRW, and its all-time low was 11760 KRW and was reached on Mar 19, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 137.00 employees. See our rating of the largest employees — is CJ BIOSCIENCE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CJ BIOSCIENCE technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CJ BIOSCIENCE stock shows the sell signal. See more of CJ BIOSCIENCE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CJ BIOSCIENCE EBITDA is ‪−26.91 B‬ KRW, and current EBITDA margin is −482.70%. See more stats in CJ BIOSCIENCE financial statements.